Sinemet CR 50mg/200 mg Prolonged-release Tablets アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

sinemet cr 50mg/200 mg prolonged-release tablets

organon pharma (ireland) limited - levodopa; carbidopa - prolonged-release tablet - dopa and dopa derivatives; levodopa and decarboxylase inhibitor

SINEMET- carbidopa and levodopa tablet アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

sinemet- carbidopa and levodopa tablet

organon llc - carbidopa (unii: mnx7r8c5vo) (carbidopa anhydrous - unii:kr87b45rgh), levodopa (unii: 46627o600j) (levodopa - unii:46627o600j) - sinemet is indicated in the treatment of parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication. carbidopa allows patients treated for parkinson's disease to use much lower doses of levodopa. some patients who responded poorly to levodopa have improved on sinemet. this is most likely due to decreased peripheral decarboxylation of levodopa caused by administration of carbidopa rather than by a primary effect of carbidopa on the nervous system. carbidopa has not been shown to enhance the intrinsic efficacy of levodopa. carbidopa may also reduce nausea and vomiting and permit more rapid titration of levodopa. nonselective monoamine oxidase (mao) inhibitors are contraindicated for use with sinemet. these inhibitors must be discontinued at least two weeks prior to initiating therapy with sinemet. sinemet may be administered concomitantly with the manufacturer's recommended dose of an mao inhibitor with selectivity for

AA-LEVOCARB CR TABLET (EXTENDED-RELEASE) カナダ - 英語 - Health Canada

aa-levocarb cr tablet (extended-release)

aa pharma inc - levodopa; carbidopa - tablet (extended-release) - 100mg; 25mg - levodopa 100mg; carbidopa 25mg - dopamine precursors

STALEVO TABLET カナダ - 英語 - Health Canada

stalevo tablet

sandoz canada incorporated - levodopa; carbidopa; entacapone - tablet - 100mg; 25mg; 200mg - levodopa 100mg; carbidopa 25mg; entacapone 200mg - catechol-o-methyltransferase (comt) inhibitors

STALEVO TABLET カナダ - 英語 - Health Canada

stalevo tablet

sandoz canada incorporated - levodopa; carbidopa; entacapone - tablet - 125mg; 31.25mg; 200mg - levodopa 125mg; carbidopa 31.25mg; entacapone 200mg - catechol-o-methyltransferase (comt) inhibitors

LEVODOPA-CARBIDOPA CR TABLET (EXTENDED-RELEASE) カナダ - 英語 - Health Canada

levodopa-carbidopa cr tablet (extended-release)

pharmascience inc - levodopa; carbidopa - tablet (extended-release) - 100mg; 25mg - levodopa 100mg; carbidopa 25mg - dopamine precursors

MINT-LEVOCARB TABLET カナダ - 英語 - Health Canada

mint-levocarb tablet

mint pharmaceuticals inc - levodopa; carbidopa - tablet - 100mg; 10mg - levodopa 100mg; carbidopa 10mg - dopamine precursors

MINT-LEVOCARB TABLET カナダ - 英語 - Health Canada

mint-levocarb tablet

mint pharmaceuticals inc - levodopa; carbidopa - tablet - 100mg; 25mg - levodopa 100mg; carbidopa 25mg - dopamine precursors

SINEMET PLUS アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

sinemet plus

merck sharp and dohme limited - levodopa carbidopa - tablets - 25/100 milligram

SINEMET PLUS アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

sinemet plus

imbat limited - levodopa carbidopa - tablets - 25/100 milligram